Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase 1/2, Open-Label, Multi-Center, Dose Escalation, Dose Expansion, and Single Repeat Dose Study of TSRA-196 in Adults With the PiZZ Genotype Who Have Lung and/or Liver Disease Associated With Severe Alpha-1 Antitrypsin Deficiency
This is a Phase 1/2, open-label, multi-center, dose escalation (Part 1), dose expansion (Part 2), and single repeat dose (Part 3) study to evaluate the safety,…
Alpha-1 Antitrypsin Deficiency (AATD)
Estimated
~$10 – $8,750
Tessera Therapeutics, Inc.NCT07227207
The Role of Conformational Diseases on Macrophage Function
The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macroph…
Alpha-1 Antitrypsin DeficiencyAAT DeficiencyAATD+1 more
Estimated
~$10 – $750
University of FloridaNCT01851642
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
Alpha-1 Antitrypsin Deficiency
Estimated
~$10 – $750
University of FloridaNCT00500123